In this video, developed in association with the European Breast Cancer Conference, Breast Cancer TV and Quadia Online Video and sponsored by an educational grant from Novartis Oncology:
- Emiel J. Rutgers, MD, Surgical Oncologist, Professor of Surgical Oncology at the University of Amsterdam (UoA), Head of Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands discusses: highlights from the clinical symposium on management of the axilla
- Anne Bodilson, MD, discusses the margin width and local recurrence in women treated by breast conserving surgery (Today?s practice changing presentation).
- Florian Fitzal, MD, Professor of Surgery, Medical University Vienna, Breast Health Center, Department of General Surgery, Vienna, Austria, discussed the tailoring local therapy in postmenopausal endocrine responsive HER2neu negative breast cancer patients based on their genetic risk profile using Endopredict, a multi-gene test for breast cancer patients, determining whether a given patient needs chemotherapy, or whether solely anti-hormonal therapy constitutes sufficient treatment. (Tomorrow?s practice changing presentation).
Copyright ? 2014 InPress Media Group/Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. InPress Media Group/Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.
